The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by O’Brien, G. C.
Right arrow Articles by Redmond, H. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by O’Brien, G. C.
Right arrow Articles by Redmond, H. P.
The Journal of Immunology, 2005, 174: 1020-1026.
Copyright © 2005 by The American Association of Immunologists

Bacterial Lipoprotein Induces Resistance to Gram-Negative Sepsis in TLR4-Deficient Mice via Enhanced Bacterial Clearance1

Gavin C. O’Brien, Jiang Huai Wang2 and H. Paul Redmond

Department of Academic Surgery, National University of Ireland, Cork University Hospital, Cork, Ireland

TLRs are highly conserved pathogen recognition receptors. As a result, TLR4-deficient C3H/HeJ mice are highly susceptible to Gram-negative sepsis. We have previously demonstrated that tolerance induced by bacterial lipoprotein (BLP) protects wild-type mice against polymicrobial sepsis-induced lethality. In this study, we assessed whether pretreatment of C3H/HeJ mice with BLP could induce resistance to a subsequent Gram-negative Salmonella typhimurium infection. Pretreatment with BLP resulted in a significant survival benefit in TLR4-deficient C3H/HeJ mice (p < 0.0002 vs control C3H/HeJ) after challenge with live S. typhimurium (0.25 x 106 CFU/mouse). This survival benefit was associated with enhanced bacterial clearance from the circulation and in the visceral organs (p < 0.05 vs control C3H/HeJ). Furthermore, pretreatment with BLP resulted in significant increases in complement receptor type 3 (CR3) and Fc{gamma}III/IIR expression on polymorphonuclear neutrophils (PMNs) and macrophages (p < 0.05 vs control C3H/HeJ). There was impaired bacterial recognition and phagocytosis in TLR4-deficient mice compared with wild-type mice. However, a significant augmented uptake, ingestion, and intracellular killing of S. typhimurium by PMNs and peritoneal macrophages was evident in BLP-pretreated C3H/HeJ mice (p < 0.05 vs control C3H/HeJ). An up-regulation of inducible NO synthase and increased production of intracellular NO were observed in peritoneal macrophages from BLP-pretreated C3H/HeJ mice (p < 0.05 vs control C3H/HeJ). Depletion of PMNs did not diminish the beneficial effects of BLP with regard to both animal survival and bacterial clearance. These results indicate that BLP, a TLR2 ligand, protects highly susceptible TLR4-deficient mice from Gram-negative sepsis via enhanced bacterial clearance.




This article has been cited by other articles:


Home page
Infect. Immun.Home page
J.-H. Park, Y.-G. Kim, and G. Nunez
RICK Promotes Inflammation and Lethality after Gram-Negative Bacterial Infection in Mice Stimulated with Lipopolysaccharide
Infect. Immun., April 1, 2009; 77(4): 1569 - 1578.
[Abstract] [Full Text] [PDF]


Home page
Poult. Sci.Home page
R. F. Wideman, O. T. Bowen, and G. F. Erf
Broiler pulmonary hypertensive responses during lipopolysaccharide-induced tolerance and cyclooxygenase inhibition
Poult. Sci., January 1, 2009; 88(1): 72 - 85.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Li, M. Komai-Koma, D. S. Gilchrist, D. K. Hsu, F.-T. Liu, T. Springall, and D. Xu
Galectin-3 Is a Negative Regulator of Lipopolysaccharide-Mediated Inflammation
J. Immunol., August 15, 2008; 181(4): 2781 - 2789.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. A. Maung, S. Fujimi, M. P. MacConmara, G. Tajima, A. M. McKenna, A. J. Delisle, C. Stallwood, A. B. Onderdonk, J. A. Mannick, and J. A. Lederer
Injury Enhances Resistance to Escherichia coli Infection by Boosting Innate Immune System Function
J. Immunol., February 15, 2008; 180(4): 2450 - 2458.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
J. C. Coffey, J. H. Wang, R. Kelly, L. Romics Jr., A. O'Callaghan, C. Fiuza, and H. P. Redmond
Tolerization with BLP down-regulates HMGB1 a critical mediator of sepsis-related lethality
J. Leukoc. Biol., October 1, 2007; 82(4): 906 - 914.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
A. Goldberg, M. Parolini, B. Y. Chin, E. Czismadia, L. E. Otterbein, F. H. Bach, and H. Wang
Toll-like receptor 4 suppression leads to islet allograft survival
FASEB J, September 1, 2007; 21(11): 2840 - 2848.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Shao, M. Lu, S. C. Katz, A. W. Varley, J. Hardwick, T. E. Rogers, N. Ojogun, D. C. Rockey, R. P. DeMatteo, and R. S. Munford
A Host Lipase Detoxifies Bacterial Lipopolysaccharides in the Liver and Spleen
J. Biol. Chem., May 4, 2007; 282(18): 13726 - 13735.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
J. M. Buckley, J. H. Wang, and H. P. Redmond
Cellular reprogramming by gram-positive bacterial components: a review
J. Leukoc. Biol., October 1, 2006; 80(4): 731 - 741.
[Abstract] [Full Text] [PDF]


Home page
Arch SurgHome page
L. Romics Jr, G. Szabo, J. C. Coffey, J. H. Wang, and H. P. Redmond
The Emerging Role of Toll-Like Receptor Pathways in Surgical Diseases
Arch Surg, June 1, 2006; 141(6): 595 - 601.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
C. H. Li, J. H. Wang, and H. P. Redmond
Bacterial lipoprotein-induced self-tolerance and cross-tolerance to LPS are associated with reduced IRAK-1 expression and MyD88-IRAK complex formation
J. Leukoc. Biol., April 1, 2006; 79(4): 867 - 875.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.